Cardica To Announce Fiscal 2014 Third Quarter Financial Results On Thursday, May 1, 2014

 Cardica To Announce Fiscal 2014 Third Quarter Financial Results On Thursday,
                                 May 1, 2014

PR Newswire

REDWOOD CITY, Calif., April 23, 2014

REDWOOD CITY, Calif., April 23, 2014 /PRNewswire/ --Cardica, Inc. (Nasdaq:
CRDC) today announced that it will release financial results for its fiscal
third quarter ended March 31, 2014, on Thursday, May 1, 2014, after the
markets close. Cardica's management will host a conference call at 4:30 p.m.
Eastern Time to discuss the financial results and provide an update on the
company's business.

Conference Call Details
To access the live conference call on May 1, 2014, at 4:30 p.m. Eastern Time
via phone, please dial 866-515-2914 from the United States and Canada or
617-399-5128 internationally. The conference ID is 65016998. Please dial in
approximately 10 minutes prior to the start of the call. A telephone replay
will be available beginning approximately four hours after the call through
May 8, 2014, and may be accessed by dialing 888-286-8010 from the United
States and Canada or 617-801-6888 internationally. The replay passcode is
34870020.

To access the live and subsequently archived webcast of the conference call,
go to the Investor Relations section of the company's website at
www.cardica.com. Please connect to the website at least 15 minutes prior to
the presentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents
Network. Individual investors can listen to the call at www.earnings.com,
Thomson's individual investor portal, powered by StreetEvents. Institutional
investors can access the call via Thomson StreetEvents at
www.streetevents.com, a password-protected event management site.

AboutCardica
Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for cardiac and laparoscopic surgical procedures.Cardica's technology
portfolio is intended to reduce operating time and facilitate
minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter
XCHANGE™ 30, a cartridge-based articulating surgical stapling device with a
five-millimeter shaft diameter, is manufactured and cleared for use in a
variety of gastrointestinal procedures and appendectomies in the United
States, and is marketed for a wide range of surgical procedures in Europe.
Cardicais developing the Cardica^® MicroCutter XCHANGE™ 45, a cartridge-based
microcutter device with an eight-millimeter shaft to be used in a variety of
procedures, including bariatric, colorectal, thoracic and general surgery. The
Cardica MicroCutter XCHANGE 45 product requires 510(k) review and CE Mark and
is not yet commercially available in the U.S. or internationally. In addition,
Cardica manufactures and markets its automated anastomosis systems, the
C-Port^® Distal Anastomosis Systems and PAS-Port^® Proximal Anastomosis System
for coronary artery bypass graft (CABG) surgery, and has shipped over 49,000
units throughout the world.

SOURCE Cardica, Inc.

Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
(650) 331-7133, investors@cardica.com
 
Press spacebar to pause and continue. Press esc to stop.